MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.

MicroRNAs (miRNAs) are small RNA molecules that inhibit gene function by suppressing translation of target genes. However, in primary central nervous system lymphoma (PCNSL), the biological significance of miRNAs is largely unknown, although some miRNAs are known to be prognosis markers. Here, we an...

Full description

Bibliographic Details
Main Authors: Yasuo Takashima, Atsushi Kawaguchi, Yasuo Iwadate, Hiroaki Hondoh, Junya Fukai, Koji Kajiwara, Azusa Hayano, Ryuya Yamanaka
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0210400
id doaj-f549c046e130414793d1c6d6be0ff256
record_format Article
spelling doaj-f549c046e130414793d1c6d6be0ff2562021-07-21T04:32:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01141e021040010.1371/journal.pone.0210400MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.Yasuo TakashimaAtsushi KawaguchiYasuo IwadateHiroaki HondohJunya FukaiKoji KajiwaraAzusa HayanoRyuya YamanakaMicroRNAs (miRNAs) are small RNA molecules that inhibit gene function by suppressing translation of target genes. However, in primary central nervous system lymphoma (PCNSL), the biological significance of miRNAs is largely unknown, although some miRNAs are known to be prognosis markers. Here, we analyzed 847 miRNAs expressed in 27 PCNSL specimens using microarray profiling and surveyed miRNA signature for prognostic prediction. Of these, 16 miRNAs were expressed in 27 PCNSL specimens at a frequency of 48%. Their variable importance measured by Random forest model revealed miR-192, miR-486, miR-28, miR-52, miR-181b, miR-194, miR-197, miR-93, miR-708, and let-7g as having positive effects; miR-29b-2*, miR-126, and miR-182 as having negative effects; and miR-18a*, miR-425, and miR-30d as neutral. After principal component analysis, the prediction formula for prognosis, consisting of the expression values of the above-mentioned miRNAs, clearly divided Kaplan-Meier survival curves by the calculated Z-score (HR = 6.4566, P = 0.0067). The 16 miRNAs were enriched by gene ontology terms including angiogenesis, cell migration and proliferation, and apoptosis, in addition to signaling pathways including TGF-β/SMAD, Notch, TNF, and MAPKinase. Their target genes included BCL2-related genes, HMGA2 oncogene, and LIN28B cancer stem cell marker. Furthermore, three miRNAs including miR-181b, miR-30d, and miR-93, selected from the 16 miRNAs, also showed comparable results for survival (HR = 8.9342, P = 0.0007), suggestive of a miRNA signature for prognostic prediction in PCNSL. These results indicate that this miRNA signature is useful for prognostic prediction in PCNSL and would help us understand target pathways for therapies in PCNSL.https://doi.org/10.1371/journal.pone.0210400
collection DOAJ
language English
format Article
sources DOAJ
author Yasuo Takashima
Atsushi Kawaguchi
Yasuo Iwadate
Hiroaki Hondoh
Junya Fukai
Koji Kajiwara
Azusa Hayano
Ryuya Yamanaka
spellingShingle Yasuo Takashima
Atsushi Kawaguchi
Yasuo Iwadate
Hiroaki Hondoh
Junya Fukai
Koji Kajiwara
Azusa Hayano
Ryuya Yamanaka
MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
PLoS ONE
author_facet Yasuo Takashima
Atsushi Kawaguchi
Yasuo Iwadate
Hiroaki Hondoh
Junya Fukai
Koji Kajiwara
Azusa Hayano
Ryuya Yamanaka
author_sort Yasuo Takashima
title MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
title_short MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
title_full MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
title_fullStr MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
title_full_unstemmed MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
title_sort microrna signature constituted of mir-30d, mir-93, and mir-181b is a promising prognostic marker in primary central nervous system lymphoma.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2019-01-01
description MicroRNAs (miRNAs) are small RNA molecules that inhibit gene function by suppressing translation of target genes. However, in primary central nervous system lymphoma (PCNSL), the biological significance of miRNAs is largely unknown, although some miRNAs are known to be prognosis markers. Here, we analyzed 847 miRNAs expressed in 27 PCNSL specimens using microarray profiling and surveyed miRNA signature for prognostic prediction. Of these, 16 miRNAs were expressed in 27 PCNSL specimens at a frequency of 48%. Their variable importance measured by Random forest model revealed miR-192, miR-486, miR-28, miR-52, miR-181b, miR-194, miR-197, miR-93, miR-708, and let-7g as having positive effects; miR-29b-2*, miR-126, and miR-182 as having negative effects; and miR-18a*, miR-425, and miR-30d as neutral. After principal component analysis, the prediction formula for prognosis, consisting of the expression values of the above-mentioned miRNAs, clearly divided Kaplan-Meier survival curves by the calculated Z-score (HR = 6.4566, P = 0.0067). The 16 miRNAs were enriched by gene ontology terms including angiogenesis, cell migration and proliferation, and apoptosis, in addition to signaling pathways including TGF-β/SMAD, Notch, TNF, and MAPKinase. Their target genes included BCL2-related genes, HMGA2 oncogene, and LIN28B cancer stem cell marker. Furthermore, three miRNAs including miR-181b, miR-30d, and miR-93, selected from the 16 miRNAs, also showed comparable results for survival (HR = 8.9342, P = 0.0007), suggestive of a miRNA signature for prognostic prediction in PCNSL. These results indicate that this miRNA signature is useful for prognostic prediction in PCNSL and would help us understand target pathways for therapies in PCNSL.
url https://doi.org/10.1371/journal.pone.0210400
work_keys_str_mv AT yasuotakashima micrornasignatureconstitutedofmir30dmir93andmir181bisapromisingprognosticmarkerinprimarycentralnervoussystemlymphoma
AT atsushikawaguchi micrornasignatureconstitutedofmir30dmir93andmir181bisapromisingprognosticmarkerinprimarycentralnervoussystemlymphoma
AT yasuoiwadate micrornasignatureconstitutedofmir30dmir93andmir181bisapromisingprognosticmarkerinprimarycentralnervoussystemlymphoma
AT hiroakihondoh micrornasignatureconstitutedofmir30dmir93andmir181bisapromisingprognosticmarkerinprimarycentralnervoussystemlymphoma
AT junyafukai micrornasignatureconstitutedofmir30dmir93andmir181bisapromisingprognosticmarkerinprimarycentralnervoussystemlymphoma
AT kojikajiwara micrornasignatureconstitutedofmir30dmir93andmir181bisapromisingprognosticmarkerinprimarycentralnervoussystemlymphoma
AT azusahayano micrornasignatureconstitutedofmir30dmir93andmir181bisapromisingprognosticmarkerinprimarycentralnervoussystemlymphoma
AT ryuyayamanaka micrornasignatureconstitutedofmir30dmir93andmir181bisapromisingprognosticmarkerinprimarycentralnervoussystemlymphoma
_version_ 1721293123863183360